@Gekkowolf When RAC was 4.5c it probably had only 60-70% of the...

@Gekkowolf When RAC was 4.5c it probably had only 60-70% of the shares listed c.w. now ... which would make it a $4-5m company then.

And ... if you go back in their announcements you can find this

https://hotcopper.com.au/threads/ann-prominent-biotech-investor-leads-investment-in-race.4913149/

Where DrT anchored the placement at 6.6c, buying 8.5m at the time (at a significant premium), roughly half the shares he has now.

ILA is perfectly set to repeat history with a premium based raise (and an anchor investor within that) to cover any shortfall from the un-exercised piggy-back options to fund the forthcoming trials.

I wonder how many ILA shareholders would now take up a 6c raise with bonus and piggy-back options, after the US grant was confirmed, if it was re-offered!

Will JC be the one? DrT? I'm waiting for a T20 to be published - might request one myself otherwise - but happy to nibble away until the end of June.